Studer Nicholas Mark 4

Accession 0001127602-25-009448

CIK 0000062709other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:01 PM ET

Size

38.1 KB

Accession

0001127602-25-009448

Insider Transaction Report

Form 4

Period: 2025-03-12

MARSH & MCLENNAN COMPANIES, INC.MMC

Studer Nicholas Mark

President and CEO of OWG

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−4,016→ 12,050 total
Exercise: $200.47Exp: 2034-02-21→ Common Stock (4,016 underlying)
Exercise/Conversion
Common Stock
2025-03-12$57.33/sh+9,408$539,314→ 20,132 total
Exercise/Conversion
Common Stock
2025-03-12$73.19/sh+10,160$743,661→ 30,292 total
Exercise/Conversion
Common Stock
2025-03-12$118.86/sh+5,217$620,119→ 35,509 total
Exercise/Conversion
Common Stock
2025-03-12$90.78/sh+4,487$407,352→ 46,147 total
Exercise/Conversion
Common Stock
2025-03-12$117.53/sh+4,270$501,853→ 50,417 total
Exercise/Conversion
Common Stock
2025-03-12$151.37/sh+14,341$2,170,768→ 64,758 total
Exercise/Conversion
Common Stock
2025-03-12$164.15/sh+8,945$1,468,277→ 73,703 total
Exercise/Conversion
Common Stock
2025-03-12$200.47/sh+4,016$805,079→ 77,719 total
Sale
Common Stock
2025-03-12$230.16/sh−49,390$11,367,746→ 28,329 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−9,408→ 0 total
Exercise: $57.33Exp: 2026-02-21→ Common Stock (9,408 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−10,160→ 0 total
Exercise: $73.19Exp: 2027-02-21→ Common Stock (10,160 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−6,151→ 0 total
Exercise: $83.05Exp: 2028-02-20→ Common Stock (6,151 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−4,487→ 0 total
Exercise: $90.78Exp: 2029-02-18→ Common Stock (4,487 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−5,217→ 0 total
Exercise: $118.86Exp: 2030-02-18→ Common Stock (5,217 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−4,270→ 0 total
Exercise: $117.53Exp: 2031-02-21→ Common Stock (4,270 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−14,341→ 4,781 total
Exercise: $151.37Exp: 2032-02-22→ Common Stock (14,341 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-03-12−8,945→ 8,946 total
Exercise: $164.15Exp: 2033-02-22→ Common Stock (8,945 underlying)
Exercise/Conversion
Common Stock
2025-03-12$83.05/sh+6,151$510,816→ 41,660 total

Footnotes (10)

[F1]Shares sold by the reporting person to satisfy exercise price and tax withholding obligations. This transaction was executed in multiple trades at prices ranging from $229.9387 to $230.36. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
[F10]These options were granted on February 22, 2024 and vest in four equal annual installments on February 22nd of 2025, 2026, 2027 and 2028.
[F2]These options were granted on February 22, 2016 and vested in four equal annual installments on February 22nd of 2017, 2018, 2019 and 2020.
[F3]These options were granted on February 22, 2017 and vested in four equal annual installments on February 22nd of 2018, 2019, 2020 and 2021.
[F4]These options were granted on February 21, 2018 and vested in four equal annual installments on February 21st of 2019, 2020, 2021 and 2022.
[F5]These options were granted on February 19, 2019 and vested in four equal annual installments on February 19th of 2020, 2021, 2022 and 2023.
[F6]These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024.
[F7]These options were granted on February 22, 2021 and vested in four equal annual installments on February 22nd of 2022, 2023, 2024 and 2025.
[F8]These options were granted on February 23, 2022 and vest in four equal annual installments on February 23rd of 2023, 2024, 2025 and 2026.
[F9]These options were granted on February 23, 2023 and vest in four equal annual installments on February 23rd of 2024, 2025, 2026 and 2027.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

MARSH & MCLENNAN COMPANIES, INC.

CIK 0000062709

→

Entity typeother

Related Parties

filerCIK 0001871327

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 4:01 PM ET
Size: 38.1 KB

View on SEC.gov